Lippincott ^® NursingCenter ^®

Featured Articles

• Free

  Breakthrough Chemotherapy-Induced Nausea & Vomiting: Control Increased with Olanzapine in Phase III Study

  Charlene Laino

• Buy

  Changing Perceptions about Unnecessary Tests Many Barriers Remain, But ASCO's New Campaign Is Key Step

  Lola Butcher

• Buy

  CLL: BTK Inhibitor Ibrutinib Promising for First-Line Treatment of Older Patients

  Robert H. Carlson

• Buy

  Crizotinib Effective for Range of ALK-Driven Pediatric Tumors

  Charlene Laino

• Buy

  Crossover Trial Validates Accelerated Approval of Sunitinib for GIST Almost Simultaneous Publication with Report at ASCO Annual Meeting about Regorafenib as Third-Line Kinase Inhibitor

  Eric T. Rosenthal

• Free

  ECOG and ACRIN Officially Merge

  Sarah Digiulio

• Buy

  Evidence that HER2 Peptide Vaccine Can Delay Recurrence in Early Breast Cancer

  Rabiya S. Tuma PhD

• Buy

  Hodgkin Lymphoma: Novel Agents Can Act as Bridge to Allogeneic Transplant for Selected Patients

  Mark Fuerst

• Buy

  How Do I Treat a Patient with Limited-Stage Small Cell Lung Cancer?

  Anne S. Tsao MD

• Buy

  Myeloma: Novel Agents Combined with Standard Therapy Show Promise for Bortezomib-Refractory Patients

  Mark Fuerst

• Free

  New Update of Urologic Diseases Report
• Buy

  Survey: Oncologists Better Informed than Primary Care Docs on Long-Term Effects of Cancer Drugs—but Still Much Room for Improvement

  Charlene Laino

• Buy

  Treating Hepatitis Infection and Liver Cancer Together

  Rabiya S. Tuma PhD